- Investing Ideas
- /
- French Pharmaceuticals & Biotech Potentially Undervalued Companies
French Pharmaceuticals & Biotech Potentially Undervalued Companies
UPDATED Apr 23, 2024
Companies with a Value score of at least 3, ordered by Value score
16 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
SAN | €88.85 | 2.4% | -15.1% | €110.9b | €107.76 | PE20.5x | E13.6% | 4.2% | ||
BOI | €34.05 | 0.3% | -12.1% | €591.2m | €39.60 | PE12.4x | E-0.3% | 3.2% | ||
IPN | €111.40 | 3.5% | 3.1% | €9.2b | €124.63 | PE14.9x | E6.0% | 1.1% | ||
GNFT | €3.24 | 1.6% | -4.0% | €160.8m | €9.38 | PS4.7x | E54.7% | n/a | ||
EAPI | €2.76 | 1.5% | -74.4% | €261.9m | €4.72 | PB0.3x | E85.2% | n/a | ||
IPH | €2.26 | 2.7% | -13.9% | €182.7m | €6.27 | PS3x | E33.0% | n/a | ||
ALPAT | €10.20 | 3.6% | -20.9% | €11.1m | €11.50 | PS4.7x | E92.7% | n/a | ||
ADOC | €8.62 | -0.6% | 202.5% | €123.2m | €9.70 | PS11.4x | E84.1% | n/a | ||
DBV | €1.21 | -5.6% | -58.7% | €116.2m | €4.78 | PS7.9x | E53.3% | n/a | ||
SANNV | €81.96 | -2.4% | n/a | €110.9b | €99.40 | PE20.5x | E13.6% | 4.2% | ||
ALDVI | €1.71 | 3.1% | -58.4% | €21.0m | €6.90 | PS6.4x | E118.1% | n/a | ||
VETO | €98.90 | 2.4% | 15.3% | €1.2b | €108.42 | PE21x | E5.0% | 0.9% | ||
ABVX | €15.18 | 8.4% | -0.5% | €955.1m | €35.74 | PS212.6x | E14.6% | n/a | ||
ALERS | €14.42 | -2.6% | -12.6% | €147.4m | €30.00 | PE30.7x | E36.3% | n/a | ||
IVA | €3.12 | -0.2% | 42.8% | €162.3m | €13.83 | PS7x | E17.6% | n/a |
Page 1 of 1